PHAT

PHAT EBITDA Margin

-14.66%TTM

Period ending:

PHAT FY EBITDA Margin%
PHAT FY EBITDA Margin2798.52%-26119.48%
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

PHAT ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Phathom Pharmaceuticals Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-87.0875%
-473.3259%
-23,320.9677%
0%
0%
0%
0%
0%

Compare ebitda margin

All PHAT financial metrics · PHAT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.